Company Bone Medical Limited Australian S.E.
Equities
AU000000BNE6
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
06-12 | Botanix Pharmaceuticals Submits Last Label Materials for Sofdra FDA Approval | MT |
05-21 | Evans & Partners Starts Botanix Pharmaceuticals at Speculative Buy With AU$0.55 Price Target | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 30/04/19 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
Chief Tech/Sci/R&D Officer | 68 | 28/02/21 | |
Henry Bosch
BRD | Director/Board Member | - | 30/06/16 |
Jack Hoblitzell
PRN | Corporate Officer/Principal | - | 23/09/21 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 28/02/21 |
Susan Park
SEC | Corporate Secretary | 49 | 16/04/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 20/02/19 |
Henry Bosch
BRD | Director/Board Member | - | 30/06/16 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
Matthew Callahan
FOU | Founder | 51 | 30/06/16 |
Daniel Sharp
BRD | Director/Board Member | - | 21/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,547,144,642 | 1,319,431,449 ( 85.28 %) | 0 | 85.28 % |
Company contact information
Botanix Pharmaceuticals Ltd.
661 Newcastle Street Unit D2
6007, Leederville
+
http://www.botanixpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+19.36% | 79.99B | |
+15.93% | 9.25B | |
+42.06% | 4.45B | |
-22.01% | 4.43B | |
+8.28% | 4.03B | |
+11.22% | 2.24B | |
-26.61% | 2.18B | |
+11.64% | 2.02B | |
-42.69% | 1.79B |
- Stock Market
- Equities
- BOT Stock
- Stock
- Company Bone Medical Limited